Clearstead Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$366K	Sell	1,123 -181	-14%	-$59K	0.01%	694
2025 Q1	$352K	Buy	1,304 +194	+17%	+$52.4K	0.01%	661
2024 Q4	$261K	Hold	1,110	–	–	﹤0.01%	772
2024 Q3	$305K	Hold	1,110	–	–	﹤0.01%	720
2024 Q2	$270K	Buy	1,110 +1,000	+909%	+$243K	﹤0.01%	720
2024 Q1	$16.5K	Sell	110 -708	-87%	-$106K	﹤0.01%	972
2023 Q4	$157K	Sell	818 -5,218	-86%	-$999K	0.01%	492
2023 Q3	$1.07M	Buy	6,036 +4,518	+298%	+$800K	0.03%	296
2023 Q2	$288K	Hold	1,518	–	–	0.02%	377
2023 Q1	$304K	Buy	1,518 +10	+0.7%	+$2K	0.02%	337
2022 Q4	$358K	Hold	1,508	–	–	0.03%	299
2022 Q3	$302K	Sell	1,508 -3,040	-67%	-$609K	0.03%	306
2022 Q2	$663K	Buy	4,548 +40	+0.9%	+$5.83K	0.05%	214
2022 Q1	$736K	Buy	4,508 +1,398	+45%	+$228K	0.05%	219
2021 Q4	$527K	Buy	3,110 +110	+4%	+$18.6K	0.04%	249
2021 Q3	$566K	Hold	3,000	–	–	0.04%	226
2021 Q2	$509K	Hold	3,000	–	–	0.04%	228
2021 Q1	$424K	Hold	3,000	–	–	0.04%	238
2020 Q4	$390K	Hold	3,000	–	–	0.04%	230
2020 Q3	$437K	Hold	3,000	–	–	0.05%	193
2020 Q2	$444K	Hold	3,000	–	–	0.05%	187
2020 Q1	$327K	Hold	3,000	–	–	0.05%	188
2019 Q4	$346K	Hold	3,000	–	–	0.04%	211
2019 Q3	$241K	Hold	3,000	–	–	0.03%	233
2019 Q2	$218K	Hold	3,000	–	–	0.03%	255
2019 Q1	$280K	Hold	3,000	–	–	0.04%	221
2018 Q4	$219K	Hold	3,000	–	–	0.03%	232
2018 Q3	$263K	Hold	3,000	–	–	0.04%	204
2018 Q2	$295K	Hold	3,000	–	–	0.04%	193
2018 Q1	$357K	Hold	3,000	–	–	0.05%	167
2017 Q4	$381K	Hold	3,000	–	–	0.05%	162
2017 Q3	$352K	Hold	3,000	–	–	0.05%	180
2017 Q2	$239K	Buy	+3,000	New	+$239K	0.03%	210